lobbying_activities: 3154775

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3154775	173df5e5-5a5a-4b63-9cf0-a774119bb567	Q1	MEHLMAN CONSULTING, INC.	284950	ASSOCIATION OF ACCESSIBLE MEDICINES	2024	first_quarter	PHA	Drug shortages. S. 775 - Increasing Transparency in Generic Drug Applications Act.	Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2024-04-19T10:47:32-04:00